Nucleus: cost and payments to doctors
What Medicare Part D paid pharmacies for Nucleus, and the payments that named it as the associated device or medical supply under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Cochlear Americas?
Cochlear Americas reported the most payments naming Nucleus. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $416K
- Providers
- 675
- Transactions
- 1,847
- Average per transaction
- $225
The per-transaction average — $225 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 675 providers the average total is $617, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Cochlear Americas | $301,167 | 72.3% |
| Cochlear Ltd | $77,423 | 18.6% |
| Cochlear AG | $12,311 | 3.0% |
| Cochlear Bone Anchored Solutions AB | $10,922 | 2.6% |
| Cochlear Latinoamerica Sociedad Anonima | $9,408 | 2.3% |
| Nihon Cochlear Co Ltd | $5,057 | 1.2% |
Other products from Cochlear Americas
The company that reported the most payments naming Nucleus also reports against these.
- Baha$2,381,331
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$1,829,371
- OSIA OSI300 IMPLANT$1,653,238
- Cochlear$853,853
- Baha BI300 implant 4 mm$176,133
- Cochlear Osia OSI200 Implant$176,133
- Osia$60,509